Study of immune and chemo resistance in colorectal tumors
Part of Cancer, Digestive system clinical trials.
This study looks at how the immune system around a colorectal tumor relates to resistance to chemotherapy. You may be able to join if you are having surgery soon for colorectal cancer and have not yet had chemotherapy before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older
- You are being treated at CHUGA for colorectal (colon) adenocarcinoma
- Your care plan includes surgery soon to remove the tumor
- You have not had chemotherapy before this surgery (you are chemo-naive)
- You agree to take part in the CRC-ORGA-2 study
- You do not have positive HIV, hepatitis B, or hepatitis C blood tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This trial collects and studies tumor and lymph node samples from people with gastric cancer who have had chemotherapy and surgery. The goal is to understand how cancer responds to treatment and to improve future care.
This trial studies how the immune system responds to colon cancer, especially when it has spread. Researchers want to understand and possibly boost immune reactions during surgery. It may help find better ways to treat colorectal cancer in the future.
This trial looks at how your immune cells change before and after surgery for colorectal cancer, and whether those changes affect your long-term recovery. It may help doctors predict outcomes and improve care.
This study looks at how bacteria in your gut, your immune system, and colon cancer interact. It aims to understand these connections to improve future treatments.
This trial tests whether adding immunotherapy (a treatment that helps your immune system fight cancer) to standard chemotherapy before surgery works better than chemotherapy alone for people with locally advanced colorectal cancer.
Hear when a new Primary Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.